María Isabel Morosini

Author

Also Known As

Irene Merino, M I Morosini, MARÍA ISABEL MOROSINI, Maria I. Morosini, Maria Isabel Morosini, María I. Morosini, María I. Morosini, María Isabel Morosini

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Ramón y Cajal Instituto Ramón y Cajal de Investigación Sanitaria Red Espanola de Investigacion en Patologia Infecciosa Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública Instituto de Salud Carlos III

About

María Isabel Morosini is an author at Hospital Universitario Ramón y Cajal specializing in medicine, clinical microbiology, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	463
2	Health Sciences	7	7	192
3	Engineering	1	1	21
4	Public Health	1	1	85
5	Biochemistry	1	1	25

María Isabel Morosini

Publications

993

Citations

H-Index

Page 1

	Year	Citations
Wide Dispersion of ST175 Clone despite High Genetic Diversity of Carbapenem-Nonsusceptible Pseudomonas aeruginosa Clinical Strains in 16 Spanish Hospitals María García-Castillo, Rosa del Campo, María Isabel Morosini, Journal of Clinical Microbiology BacteriologyPfge Pattern ComparisonAntibiotic ResistanceDrug ResistanceInfection Control	2011	85
Predicting Pseudomonas aeruginosa susceptibility phenotypes from whole genome sequence resistome analysis Sara Cortés-Lara, Ester del Barrio-Tofiño, Carla López-Causapé, Clinical Microbiology and Infection Antimicrobial Resistance GeneAntimicrobial SusceptibilityGeneticsMicrobiologyAntibiotic Resistance	2021	78
Breakpoints for Predicting <i>Pseudomonas aeruginosa</i> Susceptibility to Inhaled Tobramycin in Cystic Fibrosis Patients: Use of High-Range Etest Strips María Isabel Morosini, María García-Castillo, Elena Loza, Journal of Clinical Microbiology Antimicrobial SusceptibilityHealth SciencesAntibioticsInhaled TobramycinCystic Fibrosis Patients	2005	61
Hypermucoviscous Klebsiella pneumoniae: A challenge in community acquired infection Javier Sánchez López, Andrea García-Caballero, Carolina Navarro-San Francisco, IDCases	2019	61
Characterization of variables that may influence ozenoxacin in susceptibility testing, including MIC and MBC values Marta Tato, Yuly López, María Isabel Morosini, Diagnostic Microbiology and Infectious Disease Drug SafetyMbc ValuesAntimicrobial SusceptibilityAntibioticsSusceptibility Testing	2013	50
Alterations of the penicillin-binding proteins and murM alleles of clinical Streptococcus pneumoniae isolates with high-level resistance to amoxicillin in Spain Fabio Cafini, Rosa del Campo, Luís Alou, Journal of Antimicrobial Chemotherapy	2005	45
Antimicrobial Activity of Fosfomycin-Tobramycin Combination against Pseudomonas aeruginosa Isolates Assessed by Time-Kill Assays and Mutant Prevention Concentrations María Diez‐Aguilar, María Isabel Morosini, Ana P. Tedim, Antimicrobial Agents and Chemotherapy	2015	43
Impact of Ceftazidime-Avibactam Treatment in the Emergence of Novel KPC Variants in the ST307-Klebsiella pneumoniae High-Risk Clone and Consequences for Their Routine Detection Marta Hernández-García, Juan Antonio Castillo-Polo, Desirée Cordero, Journal of Clinical Microbiology	2022	42
Population Structure and Antimicrobial Susceptibility of Both Nonpersistent and Persistent Pseudomonas aeruginosa Isolates Recovered from Cystic Fibrosis Patients A. Fernández-Olmos, María García-Castillo, José María Alba, Journal of Clinical Microbiology Antimicrobial Resistance GenePathogenic MicrobiologyAntimicrobial SusceptibilityAntibioticsCystic Fibrosis Patients	2013	37
Carbapenemase-producing <i>Enterobacterales</i> infections in COVID-19 patients Vicente Pintado, Patricia Ruíz-Garbajosa, Rosa Escudero-Sánchez, Infectious Diseases	2021	36

Page 1